journal
https://read.qxmd.com/read/38668813/current-perspective-on-infections-and-mitigation-strategies-in-primary-systemic-vasculitis
#1
REVIEW
Manuel Carpio Tumba, Raisa Lomanto Silva, Ana B Arevalo, Sebastian E Sattui
PURPOSE OF REVIEW: The purpose of this review is to summarize and evaluate most recent evidence on the epidemiology of infections and associated risk factors in patients with primary systemic vasculitides (PSV), as well as discuss mitigation strategies including the risk of antibiotic prophylaxis. RECENT FINDINGS: Infections remain one of the leading causes of mortality in patients with PSV, with rates of severe infection ranging from 16 to 40% in different cohorts...
April 26, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38652403/antiphospholipid-patients-admitted-in-the-intensive-care-unit-what-must-the-rheumatologist-know
#2
REVIEW
Quentin Moyon, Alexis Mathian, Matthias Papo, Alain Combes, Zahir Amoura, Marc Pineton de Chambrun
PURPOSE OF THE REVIEW: Antiphospholipid syndrome (APS) is a rare systemic autoimmune disorder that can escalate into a 'thrombotic storm' called the catastrophic antiphospholipid syndrome (CAPS), frequently requiring ICU admission for multiple organ failure. This review aims to offer insight and recent evidence on critically-ill APS patients. RECENT FINDINGS: The CAPS classification criteria define this condition as the involvement of at least three organs/systems/tissues within less than a week, caused by small vessel thrombosis, in patients with elevated antiphospholipid antibodies levels...
April 23, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38575845/decoding-the-intricacies-of-statin-associated-muscle-symptoms
#3
REVIEW
Tara Fallah Rastegar, Imtiaz Ahmed Khan, Lisa Christopher-Stine
PURPOSE OF REVIEW: Hyperlipidemia is the major cardiovascular morbidity and mortality risk factor. Statins are the first-line treatment for hyperlipidemia. Statin-associated muscle symptoms (SAMS) are the main reason for the discontinuation of statins among patients. The purpose of this review is to guide clinicians to recognize the difference between self-limited and autoimmune statin myopathy in addition to the factors that potentiate them. Finally, treatment strategies will be discussed...
April 5, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38568326/aa-amyloidosis-a-contemporary-view
#4
REVIEW
Safak Mirioglu, Omer Uludag, Ozge Hurdogan, Gizem Kumru, Ilay Berke, Stavros A Doumas, Eleni Frangou, Ahmet Gul
PURPOSE OF REVIEW: Amyloid A (AA) amyloidosis is an organ- or life-threatening complication of chronic inflammatory disorders. Here, we review the epidemiology, causes, pathogenesis, clinical features, and diagnostic and therapeutic strategies of AA amyloidosis. RECENT FINDINGS: The incidence of AA amyloidosis has declined due to better treatment of the underlying diseases. Histopathological examination is the gold standard of diagnosis, but magnetic resonance imaging can be used to detect cardiac involvement...
April 3, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38512585/from-psoriasis-to-psoriatic-arthritis-ultrasound-insights-connecting-psoriasis-with-subclinical-musculoskeletal-inflammation-and-the-path-to-psoriatic-arthritis
#5
REVIEW
A L Ribeiro, L Eder
PURPOSE OF REVIEW: This review summarizes the literature about the transition from psoriasis to psoriatic arthritis (PsA), focusing on musculoskeletal ultrasound (MSUS) for detecting subclinical inflammation and its role in diagnosis and triage of high-risk patients. RECENT FINDINGS: MSUS effectively detects subclinical musculoskeletal inflammation in patients with psoriasis; however, some of these lesions are non-specific and can be found in healthy individuals...
March 21, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38492148/jak-stat-signaling-and-beyond-in-the-pathogenesis-of-spondyloarthritis-and-their-clinical-significance
#6
REVIEW
Siba P Raychaudhuri, Ruchi J Shah, Sneha Banerjee, Smriti K Raychaudhuri
PURPOSE OF REVIEW: Janus kinase-signal transducers and activators of transcription cell signaling proteins (JAK-STATs) play a key regulatory role in functioning of several inflammatory cytokines. JAK-STAT signaling proteins are the key regulators of the cytokine/cytokine receptor system involved in the pathogenesis of various autoimmune disease including spondyloarthritis (SpA). This article mainly highlights the JAK-STAT signaling system, its association with the relevant cytokine/cytokine-receptor system, and its regulatory role in pathogenesis of SpA...
March 16, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38466514/paediatric-rheumatology-fails-to-meet-current-benchmarks-a-call-for-health-equity-for-children-living-with-juvenile-idiopathic-arthritis-using-digital-health-technologies
#7
REVIEW
Sonia Butler, Dean Sculley, Derek Santos, Xavier Girones, Davinder Singh-Grewal, Andrea Coda
PURPOSE OF REVIEW: This critical review begins by presenting the history of Juvenile Idiopathic Arthritis (JIA) management. To move the conversation forward in addressing the current shortcomings that exist in the clinical management of children living with JIA, we argue that to date, the advancement of successful treatments for JIA has been historically slow. Factors implicated in this situation include a lack of rigorous research, JIA being considered a rare disease, and JIA's idiopathic and complex pathophysiology...
March 11, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38430365/osteoarthritis-as-an-enhanceropathy-gene-regulation-in-complex-musculoskeletal-disease
#8
REVIEW
Jack B Roberts, Sarah J Rice
PURPOSE OF REVIEW: Osteoarthritis is a complex and highly polygenic disease. Over 100 reported osteoarthritis risk variants fall in non-coding regions of the genome, ostensibly conferring functional effects through the disruption of regulatory elements impacting target gene expression. In this review, we summarise the progress that has advanced our knowledge of gene enhancers both within the field of osteoarthritis and more broadly in complex diseases. RECENT FINDINGS: Advances in technologies such as ATAC-seq have facilitated our understanding of chromatin states in specific cell types, bolstering the interpretation of GWAS and the identification of effector genes...
March 2, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38376666/precision-medicine-in-rheumatology-the-promise-of-ultrasound-guided-synovial-biopsy-barriers-to-its-implementation-in-the-united-states-and-proposed-solutions
#9
REVIEW
Diane Lewis Horowitz, Arthur M Mandelin, Darren Tabechian, Ami Ben-Artzi
PURPOSE OF REVIEW: In the clinical evaluation of inflammatory arthritis and the research into its pathogenesis, there is a growing role for the direct analysis of synovial tissue. Over the years, various biopsy techniques have been used to obtain human synovial tissue samples, and there have been progressive improvements in the safety, tolerability, and utility of the procedure. RECENT FINDINGS: The latest advancement in synovial tissue biopsy techniques is the use of ultrasound imaging to guide the biopsy device, along with evolution in the characteristics of the device itself...
February 20, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38372873/how-to-monitor-disease-activity-of-axial-spondyloarthritis-in-clinical-practice
#10
REVIEW
Anand Kumthekar, Nirali Sanghavi, Anuya Natu, Abhijeet Danve
PURPOSE OF REVIEW: Treatment guided by periodic and quantitative data assessment results in better outcomes compared to using clinical gestalt. While validated generic as well as specific disease activity measures for axial spondyloarthritis (axSpA) are available, there is vast scope to improve their actual utilization in routine clinical practice. In this review, we discuss available disease activity measures for axSpA, describe results from the survey conducted among general rheumatologists as well as Spondyloarthritis Research and Treatment Network (SPARTAN) members about disease activity measurement in daily practice, and discuss ways to improve axSpA disease activity using technological advances...
February 19, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38372872/thrombin-generation-assay-in-antiphospholipid-antibodies-positive-subjects-as-a-personalized-thrombotic-risk-assessment-state-of-the-art-and-perspectives
#11
REVIEW
Thomas Foret, Virginie Dufrost, Jeremy Lagrange, Patricia Costa, Guillaume Mourey, Thomas Lecompte, Nadine Magy-Bertrand, Veronique Regnault, Stéphane Zuily, Denis Wahl
PURPOSE OF THE REVIEW: Thrombotic risk assessment in antiphospholipid positive (aPL +) subjects is a major challenge, and the study of in vitro thrombin generation (thrombin generation assays (TGA)) could provide useful information. Activated protein C (APC) sensitivity is involved in thrombotic events in antiphospholipid syndrome patients. We summarized methods used to assess APC sensitivity with TGA and evaluated the prognostic role of APC resistance through literature search...
February 19, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38372871/effect-of-osteoporosis-treatments-on-osteoarthritis-progression-in-postmenopausal-women-a-review-of-the-literature
#12
REVIEW
Wang-Chun Ho, Chung-Chih Chang, Wen-Tien Wu, Ru-Ping Lee, Ting-Kuo Yao, Cheng-Huan Peng, Kuang-Ting Yeh
PURPOSE OF REVIEW: The purpose of this literature review was to determine if medications used to treat osteoporosis are also effective for treating osteoarthritis (OA). RECENT FINDINGS: A total of 40 relevant articles were identified. Studies were categorized into those (1) discussing estrogen and selective estrogen receptor modulators (SERMs), (2) bisphosphonates, (3) parathyroid hormone (PTH) analogs, and (4) denosumab, and (5) prior review articles. A large amount of evidence suggests that estrogen and SERMs are effective at reducing OA symptoms and disease progression...
February 19, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38340269/year-in-review-in-axial-spondyloarthritis-clinical-research-and-guidelines-spartan-2023-annual-meeting-proceedings
#13
REVIEW
Maureen Dubreuil
PURPOSE OF REVIEW: To highlight high impact clinical publications in spondyloarthritis from May 2022 to April 2023 that were summarized and presented at the SPARTAN annual meeting in May 2023. RECENT FINDINGS: Publications included updated guidelines on management of axial spondyloarthritis (axSpA) by ASAS-EULAR and development of a modified Juvenile Spondyloarthritis Disease Activity Index (JSpADA). Definitions were published for MRI lesions of the spine in axSpA and active and structural sacroiliac (SI) joint lesions in juvenile spondyloarthritis (JSpA)...
February 10, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38332457/dose-tapering-and-discontinuation-of-biologic-dmards-in-axial-spondyloarthritis-a-narrative-review-2023-spartan-annual-meeting-proceedings
#14
REVIEW
Haseeb Chaudhary, Mohamad Bittar, Ansaam Daoud, Marina Magrey
PURPOSE OF REVIEW: Limited data is available for tapering or discontinuation of biologic therapy in patients with axSpA who are in disease remission. The current review concentrates on published studies regarding dose tapering or withdrawal of biologics in axSpA. RECENT FINDINGS: Recent evidence in light of randomized controlled trials suggests that tapering of b-DMARDs is a feasible strategy to maintain remission or low disease activity in axSpA patients. TNF inhibitors were the studied biologics in most of these trials...
February 9, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38324125/sequence-of-events-in-the-pathogenesis-of-axial-spondyloarthritis-a-current-review-2023-spartan-meeting-proceedings
#15
REVIEW
Archita Srinath, Akihiro Nakamura, Nigil Haroon
PURPOSE OF REVIEW: Over the past two decades, significant progress has been made to untangle the etiology of inflammation and new bone formation (NBF) associated with axial spondyloarthritis (axSpA). However, exact mechanisms as to how the disease initiates and develops remain elusive. RECENT FINDINGS: Type 3 immunity, centered around the IL-23/IL-17 axis, has been recognized as a key player in the pathogenesis of axSpA. Multiple hypotheses associated with HLA-B*27 have been proposed to account for disease onset and progression of axSpA, potentially by driving downstream T cell responses...
February 7, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38300467/microbial-mechanisms-of-rheumatoid-arthritis-pathogenesis
#16
JOURNAL ARTICLE
Brenda J Seymour, Brendan E Allen, Kristine A Kuhn
PURPOSE OF REVIEW: Host-microbiome interactions have been implicated in the pathophysiology of rheumatoid arthritis (RA), but the data linking specific microbes to RA is largely associative. Here, we review recent studies that have interrogated specific mechanistic links between microbes and host in the setting of RA. RECENT FINDINGS: Several candidate bacterial species and antigens that may trigger the conversion of an anti-bacterial to an autoimmune response have been recently identified...
February 1, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38214806/erosive-hand-osteoarthritis-recent-advances-and-future-treatments
#17
REVIEW
Marta B Bean, Marta Favero, Roberta Ramonda, Carla R Scanzello
PURPOSE OF THE REVIEW: Erosive hand osteoarthritis (EHOA) is an aggressive form of hand osteoarthritis that leads to significant disability, and recent data suggests that it is increasing in prevalence. This review provides an update of our current understanding of epidemiology, genetic associations, biomarkers, pathogenesis, and treatment of EHOA, with particular focus on studies published within the last 5 years. RECENT FINDINGS: New studies of EHOA have identified new genetic loci associated with disease, including variants in genes involved in inflammation and bone remodeling...
April 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38060107/calcinosis-in-juvenile-dermatomyositis-epidemiology-pathogenesis-clinical-features-and-treatment-a-systematic-review
#18
REVIEW
Jucier Gonçalves Júnior, Samuel Katsuyuki Shinjo
PURPOSE OF REVIEW: We performed a systematic review of the literature on the epidemiology, pathogenesis, clinical and laboratory characterization, and treatment of calcinosis in patients with juvenile dermatomyositis (JDM). A qualitative systematic review was conducted from January 1975 to April 2023 according to the PRISMA protocol using three electronic databases: PubMed, Web of Science, and Scopus. Studies were analyzed based on the following eligibility criteria: at least one combination of the terms described in the search strategy appeared in the title, written in English, Portuguese, or Spanish, and addressed the epidemiology, pathogenesis, diagnosis, and treatment of calcinosis in juvenile dermatomyositis...
February 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38270842/broadening-the-scope-of-resilience-in-chronic-pain-methods-social-context-and-development
#19
REVIEW
John A Sturgeon, Caroline Zubieta, Chelsea M Kaplan, Jennifer Pierce, Anne Arewasikporn, P Maxwell Slepian, Afton L Hassett, Zina Trost
PURPOSE OF REVIEW: A wellspring of new research has offered varying models of resilience in chronic pain populations; however, resilience is a multifaceted and occasionally nebulous construct. The current review explores definitional and methodological issues in existing observational and clinical studies and offers new directions for future studies of pain resilience. RECENT FINDINGS: Definitions of pain resilience have historically relied heavily upon self-report and from relatively narrow scientific domains (e...
January 25, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38227172/understanding-spondyloarthritis-pathogenesis-the-promise-of-single-cell-profiling
#20
REVIEW
Joerg Ermann, Micah Lefton, Kevin Wei, Maria Gutierrez-Arcelus
PURPOSE OF REVIEW: Single-cell profiling, either in suspension or within the tissue context, is a rapidly evolving field. The purpose of this review is to outline recent advancements and emerging trends with a specific focus on studies in spondyloarthritis. RECENT FINDINGS: The introduction of sequencing-based approaches for the quantification of RNA, protein, or epigenetic modifications at single-cell resolution has provided a major boost to discovery-driven research...
January 16, 2024: Current Rheumatology Reports
journal
journal
34704
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.